| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 | 
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 73.95% | -0.63% | -0.08% | 23/55 | 65.82% | 我武生物 | 95.37% | 行业排名> | 
| 2025-06-30 | 74% | 0.68% | -0.17% | 25/55 | 67.7% | 我武生物 | 95.1% | 行业排名> | 
| 2025-03-31 | 74.13% | -5.83% | 1.14% | 26/55 | 69.02% | 金迪克 | 95.24% | 行业排名> | 
| 2024-12-31 | 73.29% | -10.69% | -1.52% | 27/55 | 68.55% | 我武生物 | 95.16% | 行业排名> | 
| 2024-09-30 | 74.42% | -8.43% | 1.24% | 25/55 | 69.18% | 我武生物 | 95.26% | 行业排名> | 
| 2024-06-30 | 73.51% | -7.61% | -6.62% | 22/55 | 68.3% | 西藏药业 | 95.7% | 行业排名> | 
| 2024-03-31 | 78.72% | -8.42% | -4.07% | 17/55 | 69.14% | 康华生物 | 96.08% | 行业排名> | 
| 2023-12-31 | 82.06% | -3.49% | 0.97% | 17/55 | 68.02% | 我武生物 | 95.26% | 行业排名> | 
| 2023-09-30 | 81.27% | -5.61% | 2.14% | 19/55 | 68.07% | 我武生物 | 95.4% | 行业排名> | 
| 2023-06-30 | 79.56% | -9.65% | -7.44% | 20/55 | 63.32% | 华兰疫苗 | 101.02% | 行业排名> | 
| 2023-03-31 | 85.96% | -4.33% | 1.09% | 13/55 | 69.48% | 华兰疫苗 | 100.22% | 行业排名> | 
| 2022-12-31 | 85.03% | -9.51% | -1.24% | 17/55 | 68.17% | 我武生物 | 95.39% | 行业排名> | 
| 2022-09-30 | 86.1% | -9.38% | -2.23% | 17/55 | 71.28% | 我武生物 | 95.63% | 行业排名> | 
| 2022-06-30 | 88.06% | -7.91% | -1.99% | 15/55 | 69.18% | 我武生物 | 95.75% | 行业排名> | 
| 2022-03-31 | 89.85% | -7.21% | -4.38% | 9/55 | 71.63% | 华兰疫苗 | 98.39% | 行业排名> | 
| 2021-12-31 | 93.97% | -3.01% | -1.09% | 4/55 | 72.1% | 百奥泰 | 95.74% | 行业排名> | 
| 2021-09-30 | 95.01% | -1.61% | -0.65% | 3/55 | 73.87% | 我武生物 | 95.89% | 行业排名> | 
| 2021-06-30 | 95.63% | 2% | -1.24% | 3/55 | 73.72% | 百奥泰 | 96.33% | 行业排名> | 
| 2021-03-31 | 96.83% | 7.47% | -0.05% | 1/55 | 73.03% | 义翘神州 | 96.83% | 行业排名> | 
| 2020-12-31 | 96.88% | 2% | 0.34% | 1/55 | 71.61% | 义翘神州 | 96.88% | 行业排名> | 
| 2020-09-30 | 96.56% | 2% | 7.16% | 1/55 | 73.64% | 义翘神州 | 96.56% | 行业排名> | 
| 2020-03-31 | 90.1% | 2% | 2% | 8/55 | 70.26% | 华兰疫苗 | 707.43% | 行业排名> | 

 微信公众号
                                    微信公众号
                                 证券之星APP
                                    证券之星APP
                                



